Photoinduced Copper-Catalyzed Site-Selective C(sp2)-C(sp) Cross-Coupling via Aryl Sulfonium Salts.

The classical Sonogashira reaction of aryl electrophiles in the presence of Pd catalysts has been well established as a potent method for arylalkyne synthesis. However, the site-selective C(sp2)-C(sp) cross-coupling strategy using a non-noble-metal catalyst is rare. An efficient alternative approach for the synthesis of arylalkynes via a Cu-catalyzed Sonogashira-type reaction promoted by visible light is described. This method enables site-selective alkynylation from aryl sulfonium salts derived from diverse arenes to a set of arylalkynes with high selectivity and high functional-group compatibility. Moreover, rapid alkynylation of drug molecules is demonstrated.

Synthesis and structural characterization of the mono- and diphosphine-containing diiron propanedithiolate complexes related to [FeFe]-hydrogenases. Biomimetic H2 evolution catalyzed by (mu-PDT)Fe2(CO)4[(Ph2P)2N(n-Pr)].

As the new H-cluster models, six diiron propanedithiolate (PDT) complexes with mono- and diphosphine ligands have been prepared and structurally characterized. The monophosphine model complex (mu-PDT)Fe(2)(CO)(5)[Ph(2)PNH(t-Bu)] (1) was prepared by reaction of parent complex (mu-PDT)Fe(2)(CO)(6) (A) with 1 equiv of Ph(2)PNH(t-Bu) in refluxing xylene, whereas A reacted with 1 equiv of Me(3)NO.2H(2)O in MeCN at room temperature followed by 1 equiv of Ph(2)PH to give the corresponding monophosphine model complex (mu-PDT)Fe(2)(CO)(5)(Ph(2)PH) (2). Further treatment of 2 with 1 equiv of n-BuLi in THF at -78 degrees C followed by 1 equiv of CpFe(CO)(2)I from -78 degrees C to room temperature afforded monophosphine model complex (mu-PDT)Fe(2)(CO)(5)[Ph(2)PFe(CO)(2)Cp] (3), whereas the diphosphine model complexes (mu-PDT)Fe(2)(CO)(4)(Ph(2)PC(2)H(4)PPh(2)) (4), (mu-PDT)Fe(2)(CO)(4)[(Ph(2)P)(2)N(n-Pr)] (5) and (mu-PDT)Fe(2)(CO)(4)[(Ph(2)P)(2)N(n-Bu)] (6) were obtained by reactions of A with ca.1 equiv of the corresponding diphosphines in refluxing xylene. All the new model complexes were characterized by elemental analysis, spectroscopy and particularly for 1 and 3-6 by X-ray crystallography. On the basis of electrochemical and spectroelectrochemical studies, model 5 was found to be a catalyst for HOAc proton reduction to H(2), and for this electrocatalytic reaction an ECCE mechanism was proposed.

Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis.

Insulin-induced gene 2 (Insig2) was recently identified as a putative positive prognostic biomarker for colon cancer prognosis. Insig2 has been previously reported to be an endoplasmic reticulum (ER) membrane protein, and a negative regulator of cholesterol synthesis. Here we report that Insig2 was validated as a gene with univariate negative prognostic capacity to discriminate human colon cancer survivorship. To investigate the functional roles it plays in tumor development and malignancy, Insig2 was over-expressed in colon cancer cells resulting in increased cellular proliferation, invasion, anchorage independent growth and inhibition of apoptosis. Over-expression of Insig2 appeared to suppress chemotherapeutic drug treatment-induced Bcl2 associated X protein (Bax) expression and activation. Insig2 was also found to localize to the mitochondria/heavy membrane fraction and associate with conformationally changed Bax. Moreover, Insig2 altered the expression of several additional apoptosis genes located in mitochondria, further supporting its new functional role in regulating mitochondrial mediated apoptosis. Our findings show that Insig2 is a novel colon cancer biomarker, and suggest, for the first time, a reasonable connection between Insig2 and Bax-mediated apoptosis through the mitochondrial pathway.

Synthesis, structure, and electrocatalysis of diiron C-functionalized propanedithiolate (PDT) complexes related to the active site of [FeFe]-hydrogenases.

New C-functionalized propanedithiolate-type model complexes (1-8) have been synthesized by functional transformation reactions of the known complex [(mu-SCH2)2CH(OH)]Fe2(CO)6 (A). Treatment of A with the acylating agents PhC(O)Cl, 4-pyridinecarboxylic acid chloride, 2-furancarbonyl chloride, and 2-thiophenecarbonyl chloride in the presence of Et3N affords the expected C-functionalized complexes [(mu-SCH2)2CHO2CPh]Fe2(CO)6 (1), [(mu-SCH2)2CHO2CC5H4N-4]Fe2(CO)6 (2), [(mu-SCH2)2CHO2CC4H3O-2]Fe2(CO)6 (3), and [(mu-SCH2)2CHO2CC4H3S-2]Fe2(CO)6 (4). However, when A is treated with the phosphatizing agents Ph2PCl, PCl3 and PBr3, both C- and Fe-functionalized complexes [(mu-SCH2) 2CHOPPh2-eta1]Fe2(CO)5 (5), [(mu-SCH2) 2CHOPCl2-eta1]Fe2(CO)5 (6), and [(mu-SCH2) 2CHOPBr2-eta1]Fe2(CO)5 (7) are unexpectedly obtained via intramolecular CO substitution by P atoms of the initially formed phosphite complexes. The simplest C-functionalized model complex [(mu-SCH2) 2CO]Fe2(CO)6 (8) can be produced by oxidation of A with Dess-Martin reagent. While 8 is found to be an electrocatalyst for proton reduction to hydrogen, starting complex A can be prepared by another method involving the reaction of HC(OH)(CH2Br)2 with the in situ generated (mu-LiS) 2Fe2(CO)6. X-ray crystallographic studies reveal that the bridgehead C atom of 8 is double-bonded to an O atom to form a ketone functionality, whereas the bridgehead C atoms of A, 1, 3, and 4 are equatorially-bonded to their functionalities and those of 5-7 axially-bonded to their functionalities due to formation of the corresponding P-Fe bond-containing heterocycles.